Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023 21.0% Revenue growth, 20233 Where the money goes Where each dollar of revenue went, fiscal 2023 Cost of revenue Research and development
Cost of revenue 26¢ $13.2M Research and development 73¢ $37.0M Income tax 1¢ $314.0K Out of $8.6M in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 7 3 $8.6M in 2023+21% since 2017 0 $10.0M $20.0M $30.0M 2017: $7.1M $7.1M 2017 2018: $24.1M $24.1M 2018 +239% 2019: $8.5M $8.5M 2019 −65% 2020: $3.2M $3.2M 2020 −63% 2021: $8.2M $8.2M 2021 +159% 2022: $7.1M $7.1M 2022 −14% 2023: $8.6M $8.6M 2023 +21% Gross profit4 5 6 7 3 -$4.6M in 2023-$20.0M -$10.0M 0 $10.0M 2017: $384.0K $384.0K 2017 2018: $7.9M $7.9M 2018 +1965% 2019: -$12.2M -$12.2M 2019 2020: -$2.0M -$2.0M 2020 −84% 2021: -$2.9M -$2.9M 2021 +44% 2022: -$3.8M -$3.8M 2022 +32% 2023: -$4.6M -$4.6M 2023 +21% Operating income4 5 6 7 3 -$79.5M in 2023+28% since 2017 -$200.0M -$150.0M -$100.0M -$50.0M 0 2017: -$61.9M -$61.9M 2017 2018: -$49.2M -$49.2M 2018 −21% 2019: -$154.6M -$154.6M 2019 +214% 2020: -$60.4M -$60.4M 2020 −61% 2021: -$64.6M -$64.6M 2021 +7% 2022: -$75.7M -$75.7M 2022 +17% 2023: -$79.5M -$79.5M 2023 +5% Net income4 5 6 7 3 -$78.4M in 2023−46% since 2017 -$200.0M -$150.0M -$100.0M -$50.0M 0 2017: -$144.8M -$144.8M 2017 2018: -$61.8M -$61.8M 2018 −57% 2019: -$154.2M -$154.2M 2019 +150% 2020: -$59.3M -$59.3M 2020 −62% 2021: -$62.5M -$62.5M 2021 +5% 2022: -$75.6M -$75.6M 2022 +21% 2023: -$78.4M -$78.4M 2023 +4% Revenue8 9 $2.2M in Q2 FY2024+97% since Q1 FY2024 0 $1.0M $2.0M $3.0M Q1 FY2024: $1.1M $1.1M Q1 FY2024 Q2 FY2024: $2.2M $2.2M Q2 FY2024 +97% Gross profit8 9 -$452.0K in Q2 FY2024−77% since Q1 FY2024 -$2.0M -$1.5M -$1.0M -$500.0K 0 Q1 FY2024: -$1.9M -$1.9M Q1 FY2024 Q2 FY2024: -$452.0K -$452.0K Q2 FY2024 −77% Operating income8 9 -$23.5M in Q2 FY2024−4% since Q1 FY2024 -$30.0M -$20.0M -$10.0M 0 Q1 FY2024: -$24.6M -$24.6M Q1 FY2024 Q2 FY2024: -$23.5M -$23.5M Q2 FY2024 −4% Net income8 9 -$25.7M in Q2 FY2024+14% since Q1 FY2024 -$30.0M -$20.0M -$10.0M 0 Q1 FY2024: -$22.5M -$22.5M Q1 FY2024 Q2 FY2024: -$22.5M -$22.5M Q2 FY2024 +0% Q2 FY2024: -$25.7M -$25.7M Q2 FY2024 +14% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Revenue $7.1M4 $24.1M5 $8.5M6 $3.2M6 $8.2M7 $7.1M3 $8.6M3 Cost of revenue $6.7M4 $16.2M4 $20.7M6 $5.2M6 $11.1M7 $10.9M3 $13.2M3 Gross profit $384.0K4 $7.9M5 -$12.2M6 -$2.0M6 -$2.9M7 -$3.8M3 -$4.6M3 Research and development $22.0M4 $21.8M5 $22.5M6 $16.6M6 $19.3M7 $28.9M3 $37.0M3 Operating income -$61.9M4 -$49.2M5 -$154.6M6 -$60.4M6 -$64.6M7 -$75.7M3 -$79.5M3 Interest $2.4M4 $4.2M5 $3.6M6 $19.0K6 $370.0K7 $410.0K3 $03 Income tax -$3.3M4 -$3.4M5 -$3.1M6 -$1.5M6 $225.0K7 $318.0K3 $314.0K3 Net income -$144.8M4 -$61.8M5 -$154.2M6 -$59.3M6 -$62.5M7 -$75.6M3 -$78.4M3 Earnings per share -$0.287 -$0.323 -$0.313
Total assets4 5 10 6 7 3 $59.1M in 2023−76% since 2017 0 $100.0M $200.0M $300.0M 2017: $250.3M $250.3M 2017 2018: $239.3M $239.3M 2018 −4% 2019: $74.8M $74.8M 2019 −69% 2020: $78.3M $78.3M 2020 +5% 2021: $186.5M $186.5M 2021 +138% 2022: $116.1M $116.1M 2022 −38% 2023: $59.1M $59.1M 2023 −49% Total liabilities4 5 10 6 7 3 $25.7M in 2023−64% since 2017 0 $20.0M $40.0M $60.0M $80.0M 2017: $71.4M $71.4M 2017 2018: $70.8M $70.8M 2018 −1% 2019: $19.2M $19.2M 2019 −73% 2020: $16.7M $16.7M 2020 −13% 2021: $17.2M $17.2M 2021 +3% 2022: $16.4M $16.4M 2022 −5% 2023: $25.7M $25.7M 2023 +56% Shareholders’ equity5 6 7 3 $33.4M in 2023−81% since 2017 0 $50.0M $100.0M $150.0M $200.0M 2017: $178.8M $178.8M 2017 2018: $168.5M $168.5M 2018 −6% 2019: $55.5M $55.5M 2019 −67% 2020: $61.6M $61.6M 2020 +11% 2021: $169.2M $169.2M 2021 +175% 2022: $99.6M $99.6M 2022 −41% 2023: $33.4M $33.4M 2023 −66% Cash4 5 10 6 7 3 $17.1M in 2023−81% since 2017 0 $25.0M $50.0M $75.0M $100.0M 2017: $91.2M $91.2M 2017 2018: $21.1M $21.1M 2018 −77% 2019: $9.6M $9.6M 2019 −54% 2020: $16.4M $16.4M 2020 +70% 2021: $18.1M $18.1M 2021 +11% 2022: $6.3M $6.3M 2022 −65% 2023: $17.1M $17.1M 2023 +170% Long-term debt10 6 $0 in 20210 $500.0K $1.0M $1.5M $2.0M 2019: $0 $0 2019 2020: $1.6M $1.6M 2020 2021: $0 $0 2021 Total assets8 9 $38.5M in Q2 FY2024−35% since Q1 FY2023 0 $20.0M $40.0M $60.0M Q1 FY2023: $59.1M $59.1M Q1 FY2023 Q2 FY2023: $59.1M $59.1M Q2 FY2023 +0% Q1 FY2024: $40.8M $40.8M Q1 FY2024 −31% Q2 FY2024: $38.5M $38.5M Q2 FY2024 −6% Total liabilities8 9 $49.8M in Q2 FY2024+94% since Q1 FY2023 0 $20.0M $40.0M $60.0M Q1 FY2023: $25.7M $25.7M Q1 FY2023 Q2 FY2023: $25.7M $25.7M Q2 FY2023 +0% Q1 FY2024: $27.8M $27.8M Q1 FY2024 +8% Q2 FY2024: $49.8M $49.8M Q2 FY2024 +79% Shareholders’ equity8 9 -$11.3M in Q2 FY2024-$20.0M 0 $20.0M $40.0M Q1 FY2023: $33.4M $33.4M Q1 FY2023 Q2 FY2023: $33.4M $33.4M Q2 FY2023 +0% Q1 FY2024: $13.0M $13.0M Q1 FY2024 −61% Q2 FY2024: $13.0M $13.0M Q2 FY2024 +0% Q2 FY2024: -$11.3M -$11.3M Q2 FY2024 Cash8 9 $7.8M in Q2 FY2024−54% since Q1 FY2023 0 $5.0M $10.0M $15.0M $20.0M Q1 FY2023: $17.1M $17.1M Q1 FY2023 Q2 FY2023: $17.1M $17.1M Q2 FY2023 +0% Q1 FY2024: $7.0M $7.0M Q1 FY2024 −59% Q2 FY2024: $7.8M $7.8M Q2 FY2024 +11% Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash $91.2M4 $21.1M5 $9.6M10 $16.4M6 $18.1M7 $6.3M3 $17.1M3 Current assets $113.0M4 $101.6M5 $28.0M10 $34.0M6 $113.3M7 $86.9M3 $36.4M3 Total assets $250.3M4 $239.3M5 $74.8M10 $78.3M6 $186.5M7 $116.1M3 $59.1M3 Current liabilities $28.8M4 $21.8M5 $13.0M10 $10.3M6 $9.8M7 $10.4M3 $12.6M3 Long-term debt $010 $1.6M6 $06 Total liabilities $71.4M4 $70.8M5 $19.2M10 $16.7M6 $17.2M7 $16.4M3 $25.7M3 Shareholders’ equity $178.8M5 $168.5M6 $55.5M6 $61.6M7 $169.2M3 $99.6M3 $33.4M3 Shares outstanding 216.3M shares4 16.6M shares5 20.7M shares10 116.2M shares6 235.2M shares7 236.9M shares3 264.9M shares3
Cash from operations4 5 6 7 3 -$63.6M in 2023+35% since 2017 -$80.0M -$60.0M -$40.0M -$20.0M 0 2017: -$47.3M -$47.3M 2017 2018: -$48.5M -$48.5M 2018 +3% 2019: -$73.5M -$73.5M 2019 +52% 2020: -$46.7M -$46.7M 2020 −36% 2021: -$40.7M -$40.7M 2021 −13% 2022: -$58.9M -$58.9M 2022 +45% 2023: -$63.6M -$63.6M 2023 +8% Capital spending4 5 6 7 3 $561.0K in 2023−64% since 2017 0 $500.0K $1.0M $1.5M $2.0M 2017: $1.6M $1.6M 2017 2018: $770.0K $770.0K 2018 −51% 2019: $437.0K $437.0K 2019 −43% 2020: $3.0K $3.0K 2020 −99% 2021: $1.4M $1.4M 2021 +45500% 2022: $1.3M $1.3M 2022 −7% 2023: $561.0K $561.0K 2023 −56% Free cash flow4 5 6 7 3 -$64.2M in 2023+31% since 2017 -$80.0M -$60.0M -$40.0M -$20.0M 0 2017: -$48.9M -$48.9M 2017 2018: -$49.3M -$49.3M 2018 +1% 2019: -$73.9M -$73.9M 2019 +50% 2020: -$46.7M -$46.7M 2020 −37% 2021: -$42.0M -$42.0M 2021 −10% 2022: -$60.2M -$60.2M 2022 +43% 2023: -$64.2M -$64.2M 2023 +7% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash from operations -$47.3M4 -$48.5M5 -$73.5M6 -$46.7M6 -$40.7M7 -$58.9M3 -$63.6M3 Capital spending $1.6M4 $770.0K5 $437.0K6 $3.0K6 $1.4M7 $1.3M3 $561.0K3 Free cash flow -$48.9M -$49.3M -$73.9M -$46.7M -$42.0M -$60.2M -$64.2M
Compare ASENSUS SURGICAL, INC. with another company
Former names
TRANSENTERIX, INC. Aug 8, 2019 to Feb 23, 20212 TRANSENTERIX INC. Nov 8, 2013 to Jul 10, 20192 SafeStitch Medical, Inc. Feb 12, 2008 to Dec 10, 20132 CELLULAR TECHNICAL SERVICES CO INC Jul 19, 1996 to Feb 11, 20082
Recent filings
Aug 22, 2024 8-K Aug 22, 2024 4 STARLING FORM 4Aug 22, 2024 4 BIFFI FORM 4 AUG 22, 2024Aug 22, 2024 4 SHAMEZE FORM 4 AUG 22, 2024Aug 22, 2024 4 AF FORM 4 AUG 22, 2024Aug 22, 2024 4 MILNE FORM 4 AUG 22, 2024Aug 22, 2024 4 RCP AUG 22, 2024Aug 22, 2024 4 HOBERT FORM 4 AUG 22, 2024Aug 22, 2024 4 KWO FORM 4 AUG 22, 2024Aug 20, 2024 8-K Aug 13, 2024 10-Q Aug 13, 2024 8-K Jul 29, 2024 8-K Jun 7, 2024 8-K May 15, 2024 8-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
